These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15809729)

  • 21. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer.
    Hsu CP; Shen GH; Ko JL
    Lung Cancer; 2006 Jun; 52(3):349-57. PubMed ID: 16569461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of plasma matrix metalloproteases 2, 3, 9 in breast carcinomas and fibroadenomas].
    Solai F; Nardo T; Patrizi G; Annessi M; Santulli M; Amabile MI; Vasaturo F
    G Chir; 2010; 31(8-9):365-7. PubMed ID: 20843437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low serum level of pro-matrix metalloproteinase 2 correlates with aggressive behavior in breast carcinoma.
    Kuvaja P; Talvensaari-Mattila A; Pääkkö P; Turpeenniemi-Hujanen T
    Hum Pathol; 2006 Oct; 37(10):1316-23. PubMed ID: 16949931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased plasma levels of urokinase plasminogen activator and matrix metalloproteinase-9 in nonsmall cell lung cancer patients.
    Yang SF; Hsieh YS; Lin CL; Hsu NY; Chiou HL; Chou FP; Chu SC
    Clin Chim Acta; 2005 Apr; 354(1-2):91-9. PubMed ID: 15748604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The significance of serum active matrix metalloproteinase-9 in patients with non-small cell lung cancer.
    Ondo K; Sugio K; Yamazaki K; Yamaguchi M; Yano T; Yoshino I; Maehara Y
    Lung Cancer; 2004 Nov; 46(2):205-13. PubMed ID: 15474669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary gelatinase activities (matrix metalloproteinases 2 and 9) in human bladder tumors.
    Di Carlo A; Terracciano D; Mariano A; Macchia V
    Oncol Rep; 2006 May; 15(5):1321-6. PubMed ID: 16596205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
    Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
    Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancer.
    Byun JH; Lee MA; Roh SY; Shim BY; Hong SH; Ko YH; Ko SJ; Woo IS; Kang JH; Hong YS; Lee KS; Lee AW; Park GS; Lee KY
    Jpn J Clin Oncol; 2006 May; 36(5):263-8. PubMed ID: 16735371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their tissue natural inhibitors in breast tumors.
    Jinga D; Stefanescu M; Blidaru A; Condrea I; Pistol G; Matache C
    Roum Arch Microbiol Immunol; 2004; 63(3-4):141-58. PubMed ID: 17240786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
    Kim SH; Choi HY; Lee J; Son DS; Lee HS; Song IS; Lim YS; Hong YS; Kim J; Choi YS
    J Surg Oncol; 2007 Mar; 95(4):337-46. PubMed ID: 17326127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinases in blood from patients with LAM.
    Odajima N; Betsuyaku T; Nasuhara Y; Inoue H; Seyama K; Nishimura M
    Respir Med; 2009 Jan; 103(1):124-9. PubMed ID: 18760908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
    Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
    Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression.
    Redondo P; Lloret P; Idoate M; Inoges S
    Clin Exp Dermatol; 2005 Sep; 30(5):541-5. PubMed ID: 16045689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer.
    Iniesta P; Morán A; De Juan C; Gómez A; Hernando F; García-Aranda C; Frías C; Díaz-López A; Rodríguez-Jiménez FJ; Balibrea JL; Benito M
    Oncol Rep; 2007 Jan; 17(1):217-23. PubMed ID: 17143501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between N-linked oligosaccharide chains of human serum immunoglobulin G and serum tumor markers with non-small cell lung cancer progression.
    Kanoh Y; Ohara T; Mashiko T; Abe T; Masuda N; Akahoshi T
    Anticancer Res; 2006; 26(6B):4293-7. PubMed ID: 17201147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma.
    Gao ZL; Zhang C; Du GY; Lu ZJ
    Hepatogastroenterology; 2007; 54(77):1591-5. PubMed ID: 17708308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
    Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
    Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum MMP-9 level associated with initiation and progression steps of breast cancer in the Iranian population.
    Motovali-Bashi M; Sadeghi M; Hemmati S
    Reprod Sci; 2010 Jun; 17(6):585-9. PubMed ID: 20338991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions.
    Li CS; Cheng BC; Ge W; Gao JF
    Int J Clin Pract; 2007 Mar; 61(3):444-8. PubMed ID: 17313612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of serum matrix metalloproteinase-2 and -9 to predict breast cancer progression.
    Patel S; Sumitra G; Koner BC; Saxena A
    Clin Biochem; 2011 Jul; 44(10-11):869-72. PubMed ID: 21565179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.